Author:
Lu Tzung-Ju,Chen Chuang-Wei,Hsiao Koung-Hung
Funder
Buddhist Tzu Chi Medical Foundation
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. Administration HP, Welfare Moha, Taiwan. Cancer Registry Annual Report, 2016 Taiwan. 2018.
2. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12(6):575–582
3. Sadahiro S, Suzuki T, Ishikawa K, Nakamura T, Tanaka Y, Masuda T et al (2003) Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years. Hepatogastroenterology 50(53):1362–1366
4. Pugh SA, Shinkins B, Fuller A, Mellor J, Mant D, Primrose JN (2016) Site and stage of colorectal cancer influence the likelihood and distribution of disease recurrence and postrecurrence survival: data from the FACS randomized controlled trial. Ann Surg 263(6):1143–1147
5. Westberg K, Palmer G, Hjern F, Johansson H, Holm T, Martling A (2018) Management and prognosis of locally recurrent rectal cancer - a national population-based study. Eur J Surg Oncol 44(1):100–107